Henan, China

Ruifang Han


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ruifang Han in Nanoparticle Therapeutics

Introduction

Ruifang Han is a notable inventor based in Henan, China. He has made significant contributions to the field of nanoparticle therapeutics, particularly in the treatment of skin conditions such as psoriasis. His innovative approach combines advanced materials with therapeutic applications, showcasing the potential of nanotechnology in medicine.

Latest Patents

Ruifang Han holds a patent for a self-therapeutic nanoparticle designed for enhanced topical delivery to skin keratinocytes and treating skin inflammation. This patent details a composition that includes an anti-psoriatic drug, which is delivered through a unique formulation involving gold nanoparticles and polyethylene glycol (PEG) strands. The design optimizes the distribution of the drug within skin cells, enhancing permeability and effectiveness in treating psoriasis.

Career Highlights

Han is affiliated with The Chinese University of Hong Kong, where he engages in research that bridges the gap between nanotechnology and dermatological therapies. His work emphasizes the importance of innovative drug delivery systems in improving patient outcomes for skin-related ailments.

Collaborations

Ruifang Han collaborates with esteemed colleagues such as Chung Hang Jonathan Choi and Lok Wai Cola Ho. These partnerships enhance the research and development of novel therapeutic strategies in the field of dermatology.

Conclusion

Ruifang Han's contributions to nanoparticle therapeutics represent a significant advancement in the treatment of skin conditions. His innovative patent and collaborative efforts highlight the potential of nanotechnology in enhancing drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…